Cargando…

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan

BACKGROUND: Diabetic nephropathy is the most important cause of end stage renal disease (ESRD). Aldosterone is involved in renal damage through induction of fibrosis, inflammation and necrosis in the kidney tissue. Previous studies have demonstrated that the combination of angiotensin receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makhlough, Atieh, Kashi, Zahra, Akha, Ozra, Zaboli, Ehsan, Yazdanicharati, Jamshid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968951/ https://www.ncbi.nlm.nih.gov/pubmed/24719811 http://dx.doi.org/10.5812/numonthly.12148

Ejemplares similares

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
por: Lee, Mi Young, et al.
Publicado: (2011)

Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction
por: LIU, YAN, et al.
Publicado: (2014)

Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes
por: Dong, Dan, et al.
Publicado: (2019)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Evaluation of early left-sided cardiac reverse remodeling under combined therapy of sacubitril-valsartan and spironolactone compared with angiotensin-converting enzyme inhibitors and spironolactone
por: Sacharczuk, Wioletta, et al.
Publicado: (2023)

The effect of spironolactone on diastolic function in haemodialysis patients
por: Hauser, T., et al.
Publicado: (2021)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Comparing the Levels of Trace Elements in Patients With Diabetic Nephropathy and Healthy Individuals
por: Makhlough, Atieh, et al.
Publicado: (2015)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
por: Coffman, Melissa, et al.
Publicado: (2021)

DRESS Syndrome Secondary to Spironolactone with Atypical Presentation
por: Bains, Anupama, et al.
Publicado: (2020)

Therapeutic Efficacy of Spironolactone for Central Serous Chorioretinopathy
por: Han, Jae Yong, et al.
Publicado: (2022)

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018)

The Effect of Spironolactone on the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Cardiac Catheterization: Study Design and Rationale
por: Mujtaba, Alhasan, et al.
Publicado: (2018)

Treatment of Acne Vulgaris by Topical Spironolactone Solution Compared With Clindamycin Solution
por: Noaimi, Adil, et al.
Publicado: (2021)

Spironolactone Effect in Hepatic Ischemia/Reperfusion Injury in Wistar Rats
por: Jiménez Pérez, Julio César, et al.
Publicado: (2016)

Mechanisms Involved in the Beneficial Effects of Spironolactone after Myocardial Infarction
por: Minicucci, Marcos F., et al.
Publicado: (2013)

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients
por: Langote, Amit, et al.
Publicado: (2017)

Comparative Evaluation of Captopril, Spironolactone, and Carvedilol Effect on Endothelial Function in Breast Cancer Women Undergoing Chemotherapy
por: Hashemi Jazi, Seyed Mohammad, et al.
Publicado: (2023)

Use, tolerability and compliance of spironolactone in the treatment of heart failure
por: Lachaine, Jean, et al.
Publicado: (2011)

Agranulocytosis Associated With Spironolactone Therapy: A Case Report
por: Fershko, Adam A., et al.
Publicado: (2011)

S47. ADD-ON SPIRONOLACTONE FOR THE TREATMENT OF SCHIZOPHRENIA (SPIRO TREAT)
por: Roeh, Astrid, et al.
Publicado: (2018)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful?
por: Pun, Patrick H.
Publicado: (2023)

Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
por: Wong, Calvin W, et al.
Publicado: (2023)

Effects of cabergoline on blood glucose levels in type 2 diabetic patients: A double-blind controlled clinical trial
por: Bahar, Adele, et al.
Publicado: (2016)

Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment
por: Choy, Manting, et al.
Publicado: (2022)

A randomised, controlled, double-blind, cross-over pilot study assessing the effects of spironolactone, losartan and their combination on heart rate variability and QT dispersion in patients with chronic heart failure
por: Shehab, A, et al.
Publicado: (2008)

Development and evaluation of solid dispersion of spironolactone using fusion method
por: Shamsuddin,, et al.
Publicado: (2016)

Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration
por: Kapoor, Kapil G., et al.
Publicado: (2017)

The Utility of Potassium Monitoring in Gender-Diverse Adolescents Taking Spironolactone
por: Millington, Kate, et al.
Publicado: (2019)

Use of Spironolactone in SARS-CoV-2 ARDS Patients
por: Dumanlı, Güleren Yartaş, et al.
Publicado: (2020)

Spironolactone and XPB: An Old Drug with a New Molecular Target
por: Gabbard, Ryan D., et al.
Publicado: (2020)

Modification of ventriculo–arterial coupling by spironolactone in nonischemic dilated cardiomyopathy
por: Lawson, Mark A., et al.
Publicado: (2021)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

Sex Differences in Spironolactone and the Active Metabolite Canrenone Concentrations and Adherence
por: Peeters, Laura E. J., et al.
Publicado: (2022)

Efficacy of Spironolactone Treatment in Murine Models of Cutaneous and Visceral Leishmaniasis
por: Andrade-Neto, Valter Viana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aml9ec6go5tf9t4acjldb5fs0v